Moderna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck
Moderna Inc (NASDAQ: MRNA), a company founded in 2010, is now worth more than the 130-year old Merck & Co., Inc (NYSE: MRK) in terms of market capitalization.
Microvast Continues To See Sky-High WalllStreetBets Interest — These Are The Other Top Trends
Microvast Holdings Inc. (NASDAQ: MVST) has emerged as the most-discussed stock on Reddit’s r/WallStreetBets forum as of Monday night, while Moderna Inc. (NASDAQ: MRNA), AMC Entertainment Holdings Inc.
Moderna Continues To Fly Higher: What’s Next?
Moderna Inc. (NASDAQ: MRNA) shares rallied higher Monday after vaccine stocks continue trading higher with Delta variant worries. The company also reportedly received Swiss approval for the use of the vaccine in 12 to 17 year olds.
Moderna shares closed up 17% at $484.47.
Moderna And Netease Gain In A Mixed Day For The Markets
U.S. indices had a mixed day of trading Monday as investors weigh Friday’s better-than-expected jobs data, infrastructure news and recent earnings.
Why This Investor Just Compared Moderna To Amazon, Sees 500% Upside
Short Hills Capital's Steve Weiss shared Monday on CNBC's "Fast Money Halftime Report" that he is adding to his Moderna Inc (NASDAQ: MRNA) stock position.
10 Health Care Stocks Showing Unusual Options Activity In Today’s Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
What’s Going On With Moderna’s Stock Today?
Moderna Inc (NASDAQ: MRNA) is trading higher Monday as growing COVID-19 concerns lift vaccine makers. The company's COVID-19 vaccine was also granted provisional registration by the Australian Therapeutic Goods Administration.
Unusual Options Activity Insight: Moderna
Moderna (NASDAQ:MRNA) shares experienced unusual options activity on Monday. The stock price moved up to $430.86 following the option alert.